Walt Disney Co. (NYSE:DIS) advanced nearly 5% in pre-market trading on Wednesday after reporting third-quarter adjusted earnings that comfortably exceeded analysts' expectations, even though quarterly revenue came in slightly below forecasts. Investors welcomed the stronge
By Mrinalika Roy and Mariam Sunny Aug 5 Sales of Eli Lilly's Zepbound and Mounjaro injectable weight-loss and diabetes drugs soared during the second quarter, easily beating Wall Street estimates and widening the gap with Danish rival Novo Nordisk. The trillion-dollar comp
Stablecoin issuer Circle reports $0.18 EPS, above forecasts, while revenue falls short at $701 million for the quarter. Circle Internet Financial reported second-quarter earnings per share of $0.18, surpassing analysts' expectations of $0.16. However, revenue reached $701
What happened: Eli Lilly (LLY) stock jumped as much as 7% on Wednesday. What's behind the move: The drug company raised its 2026 sales forecast after it saw strong demand for GLP-1 drugs in its fiscal second quarter Revenue is now expected to fall between $85 billio
SpaceX stock fell despite beating Q2 estimates as rising costs and insider share unlocks weigh on sentiment. SpaceX (SPCX) shares dropped sharply early Wednesday, retreating toward post-IPO lows despite the company surpassing Q2 earnings expectations in its first report as
Warner Bros. Discovery earnings expected to be -$0.11 per share Warner Bros. Discovery is set to announce its Q2 2026 earnings results on August 6th. The company's consensus EPS estimate is -$0.11, with a consensus revenue estimate of $9.21 billion, representing a 6.1
Strong quarterly results from Disney and Eli Lilly drive investor optimism, pushing major U.S. stock indices to all-time highs. The S&P 500 surged to a record intraday high Wednesday, supported by robust corporate earnings and easing geopolitical tensions. The Dow Jones In
A senior source confirms no discussions are underway between the drugmakers, ending rumors of a potential $400 billion deal. AstraZeneca and Bristol Myers Squibb have no active merger discussions, a senior source said, dismissing reports of a potential $400 billion tie-up.
Quick Read - Eli Lilly Q2 revenue surged 48% to $23 billion as Mounjaro hit $9.9 billion in quarterly sales, claiming the title of world's best-selling drug. - Lilly and Nvidia are committing up to $1 billion over five years to a joint AI lab targeting faster drug discovery and...</strong
CVS raised its full-year outlook modestly despite a Q2 earnings surge driven by lower health benefit costs. CVS Health reported Q2 earnings that surpassed forecasts as health benefit costs declined as a share of premiums. The company increased its full-year outlook, but th
ادخل بحساب جوجل لمشاركة رأيك والتفاعل مع الأخبار — بلا كلمة مرور.
إيميلك يبقى موثّقاً وخصوصيتك محفوظة.